0.7323
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Gt Biopharma Inc Borsa (GTBP) Ultime notizie
Is GT Biopharma Inc. stock attractive for retirement portfolios2026 world cup usa national team semifinals young talents build up play odds analysis analysis - ulpravda.ru
Fibonacci Retracement Aligns with Support in Ballarpur Industries LimitedReal Estate Investment Trusts & Affordable Trading Plans - bollywoodhelpline.com
Big Money Moves: Why GT Biopharma Inc stock attracts high net worth investorsBear Alert & Stepwise Trade Execution Plans - moha.gov.vn
GTBP overperforms with a 10.54 increase in share price - uspostnews.com
GT Biopharma, Inc.Common Stock (NQ: GTBP - FinancialContent
Is GT Biopharma Inc. (OXIA) stock trading at attractive multiplesMomentum Trading Signals & Small Budget Trading Ideas - Bollywood Helpline
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
Risk Report: Why GT Biopharma Inc OXIA stock is a strong analyst pickWatch List & Advanced Swing Trade Entry Alerts - moha.gov.vn
Is GT Biopharma Inc. (OXIA) stock suitable for passive index fundsQuarterly Growth Report & Technical Entry and Exit Tips - Улправда
Can GT Biopharma Inc. (OXIA) stock sustain breakout momentumRate Cut & Daily Entry Point Alerts - Улправда
Will GT Biopharma Inc. stock deliver long term returnsCEO Change & Safe Investment Capital Preservation Plans - Улправда
Why retail investors pile into GT Biopharma Inc. stockWeekly Trade Review & Low Drawdown Investment Ideas - Улправда
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - The Globe and Mail
Why GT Biopharma Inc. (OXIA) stock is a strong analyst pickQuarterly Earnings Summary & Consistent Income Trade Recommendations - DonanımHaber
Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 - Sahm
Why GT Biopharma Inc. stock attracts high net worth investorsTrade Performance Summary & Stock Market Timing Techniques - DonanımHaber
Is GT Biopharma Inc. (OXIA) stock safe for risk averse investorsTrade Exit Summary & Risk Controlled Swing Trade Alerts - DonanımHaber
S P Trends: Is GT Biopharma Inc. (OXIA) stock safe for risk averse investorsInflation Watch & Reliable Intraday Trade Alerts - DonanımHaber
Is GT Biopharma Inc. stock supported by strong cash flows2025 Buyback Activity & Real-Time Volume Surge Alerts - Улправда
How GT Biopharma Inc. (OXIA) stock correlates with oil markets2025 Winners & Losers & Community Consensus Trade Signals - ulpravda.ru
THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis - GlobeNewswire Inc.
GT Biopharma Inc Stock Analysis and ForecastEarnings Surprise Analysis & Free Get High Impact Recommendations - earlytimes.in
GT Biopharma Inc OXIA Stock Analysis and ForecastStraddle and Strangle Trades & Free High Yield Portfolio Picks - earlytimes.in
Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com
GT Biopharma, Inc. Reports Continued Progress with Its Phase 1 Clinical Trial of GTB-3650 - marketscreener.com
THE REALITY CHECK: 5 Assets Delivering Proof in a Speculative Market - The Manila Times
What is GT Biopharma Inc (GTBP) Stock Return on Shareholders’ Capital? - setenews.com
GT Biopharma (GTBP) Stock Analysis Report | Financials & Insights - Benzinga
Why GT Biopharma Inc. (OXIA) stock could rally stronglyJuly 2025 Recap & Daily Price Action Insights - Newser
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - KamloopsBCNow
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points (2025-12-04) - Seeking Alpha
What technical charts say about GT Biopharma Inc. stockTrade Volume Summary & Free Technical Pattern Based Buy Signals - Newser
What is the fair value estimate for GT Biopharma Inc. (OXIA) stock in 2025July 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
The growth track for GT Biopharma Inc (GTBP) has changed recently - Setenews
What Wall Street predicts for GT Biopharma Inc. stock priceTrade Entry Report & Fast Exit and Entry Strategy Plans - Newser
Is GT Biopharma Inc. (OXIA) stock a buy on weaknessWeekly Trade Analysis & Free Risk Controlled Daily Trade Plans - Newser
How supply chain issues affect GT Biopharma Inc. stockRate Hike & Consistent Income Trade Ideas - Newser
How reliable is GT Biopharma Inc. (OXIA) stock dividend growthWeekly Volume Report & AI Forecast for Swing Trade Picks - Newser
What drives GT Biopharma Inc stock priceShort Interest Overview & Superior Trading Portfolio - earlytimes.in
GT Biopharma faces Nasdaq bid-price deficiency, eyes compliance options - Stock Titan
A History of Outperforming Analyst Forecasts and Beating the Odds: GT Biopharma Inc (GTBP) - Setenews
GT Biopharma shares advance as flagship GTB 3650 trial escalates to next dose level - MSN
GT Biopharma (GTBP) Price Target Decreased by 27.27% to 8.16 - MSN
How GT Biopharma Inc. (OXIA) stock responds to job market shiftsMarket Growth Report & Growth Oriented Trade Recommendations - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):